focus -WSS

focus

author：Wikipedia 2025-09-30 18:16:16 - browse：673

ANDREW YATES/AFP via Getty Images

WASHINGTON — A federal judge in Delaware on Friday ruled against AstraZeneca in a case challenging the constitutionality of Medicare’s new drug price negotiation program.

Colm Connolly, chief judge of the U.S. District Court of Delaware, ruled against the company on all its major arguments. He wrote that AstraZeneca had not proved that Medicare’s new drug price negotiation program jeopardizes its constitutional property rights, and that the company didn’t have standing to challenge the guidance Medicare issued to implement the program.

The case is the first of a slew of cases filed by the pharmaceutical industry and its allies to be decided at the district court level. The Delaware ruling is a blow, as several of the other cases made similar arguments about how the program violates drugmakers’ constitutional property rights.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： UCB departs biotech trade group BIO

knowledge

WSS

RaDonda Vaught to speak at CommonSpirit event on patient safety

RSV vaccines may be linked to small increased risk of developing GBS

UCB departs biotech trade group BIO

A single drug, study failures leave Anavex with nothing but cash

Clinical trials giant ICON acquires HumanFirst

RSV vaccines may be linked to small increased risk of developing GBS

focus

focus

entertainment

Wildfire smoke exposes gaps in outdoor worker protections

How a scoliosis diagnosis changed the life of one young dancer

Sports medicine is finally prioritizing gender equality

Covid isolation guidance eased by the CDC

What does generative AI mean for health care? We asked experts

How a scoliosis diagnosis changed the life of one young dancer

New air purifier tech could be key to improving indoor air quality

AstraZeneca loses challenge to Medicare drug price negotiation

Dobbs anniversary: the lost opportunity of abortion as health care

How to fix the rural physician shortage in the U.S.

leisure time

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

UCB departs biotech trade group BIO

Federal weight loss drug coverage is 30 years out of date

White House finalizes ITC's import ban of latest Apple Watches

Change Healthcare cyberattack outage could last weeks

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

focus

Wikipedia

knowledge

hotspot